Stroke, Acute Clinical Trial
Official title:
Electrical Somatosensory Stimulation of the Paretic Upper Limb in Acute Stroke Patients - a Randomized Controlled Study
This study evaluates the effect of electrical somatosensory stimulation (ESS) on the restoration of upper limb functioning in acute stroke patients. The effect will be measured at the end of the intervention and six months post-stroke. We expect that ESS facilitates the restoration of upper limb functioning and the brain reorganization following stroke.
1. Introduction
Globally, stroke is ranked as the second leading cause of death and the third largest
cause of disease burden. Stroke is associated with tremendous physical, psychological
and economical demands on patients, families, the health care system and society at
large. The worldwide burden of stroke is expected to increase in the coming years. In
the developed countries, this trend is primarily a consequence of the growing older
population; age being a major risk factor for stroke. Upper limb paresis is one of the
most frequent and persisting impairments following stroke, and represents a major
obstacle to regain independence in activities of daily living (ADL). In fact, it has
been estimated that about 50% of the stroke survivors will be left with a non-functional
arm after completed stroke rehabilitation. In order to minimize the disease burden in
stroke survivors, it is of great importance to design and implement effective
rehabilitation strategies targeting the paretic upper limb.
Studies have shown that recovery of upper limb functioning (i.e. recovery of impairments
and activity limitations, including skills) follows a pattern with a pronounced early
post-stroke recovery and a subsequent leveling off already by 6 months post-stroke. In
fact, it has been shown that 80% of patients reached a plateau within 3 weeks, and 95%
reached a plateau by 9 weeks. It has also been shown that regaining hand dexterity is
largely defined within the first 4 weeks after stroke , indicating a critical time
window for recovery of upper limb functioning. Therefore rehabilitation efforts in the
early post-stroke phase are likely decisive to maximize functional recovery. However,
despite the fact that recovery is most likely in the immediate weeks after stroke, there
are very few studies investigating the effect of therapeutic interventions in this time
period.
Several therapeutic interventions are currently used to try to aid in the recovery of
upper limb functioning. There is limited evidence that hands-on therapy, including
passive joint mobilization, manual stretching of soft tissue and passive exercises, is
effective. Strength training in chronic stroke may reduce motor impairments in patients
with mild-moderate paresis, but without any effect on ADL-performance. Likewise, there
is limited evidence for the use of mirror therapy, sensorimotor and mental training. The
evidence for using orthoses and other supporting devices is inconclusive. Repetitive
task-oriented practice, which is probably the widest used intervention in facilitating
upper limb recovery after stroke, has demonstrated promising results mostly in chronic
stroke when delivered using virtual reality systems and robots, as well as
constrained-induced movement therapy. However, these approaches are patient and resource
demanding in terms of hours of daily training or expensive technologies. Moreover, it
remains unknown if the functional benefits persist at long-term.
Electrical stimulation (ES) is another method that has been used in facilitating the
recovery of upper limb functioning following stroke. ES can induce a muscle contraction,
or it can be a somatosensory stimulation below the motor threshold. Regardless the type
of stimulation, there is some evidence that ES can aid in reducing motor impairments,
but the questions regarding the optimal stimulation protocol (e.g. current amplitude,
pulse frequency, placement of electrodes, treatment duration), long-term effect and
transfer of training effect into ADL remains unanswered. Since this body of evidence is
primarily based upon studies conducted on ES in chronic stroke patients, it also remains
unknown to what extent ES applied in the acute phase after stroke could affect the
recovery of upper limb functioning. Although the vast majority of the studies have
focused on ES that induces muscle contraction, it is widely accepted that somatosensory
input is required for maintaining normal motor function. Research shows that motor
skills acquisition and motor performance are dependent on somatosensory input, and
stroke patients with intact somatosensory function experience more satisfactory response
to rehabilitation. In healthy persons, the application of electrical somatosensory
stimulation (ESS) to peripheral hand nerves, forearm muscles or the whole hand elicits
an increase in the cortical excitability of the representations that control the
stimulated body parts, and the increased cortical excitability seems to outlast the
stimulation period itself. It has been hypothesized that increasing the amount of
somatosensory input may enhance the motor recovery of patients following stroke. Recent
studies in acute, subacute and mostly chronic stroke patients suggest that a single 2
hours-session of ESS to the peripheral hand nerves leads to transient improvement of
pinch force, movement kinematics and upper limb motor skills required for
ADL-performance. The higher the current amplitude, the more prominent the effect seems
to be. ESS is used in conjunction with motor training in only one of these studies. One
study demonstrates that the effect of a single session of ESS is maintained 30 days
after cessation of intervention. Interestingly, there is emerging evidence that multiple
sessions of ESS to the peripheral hand nerves in conjunction with motor training might
improve motor skills of the paretic upper limb in subacute and chronic stroke patients,
and these positive results seems to outlast the intervention period. When ESS is
delivered in multiple sessions, it is unclear which current amplitude is optimal in
subacute stroke patients. ESS of the whole hand using glove electrodes may or may not
benefit the motor recovery of the paretic upper limb in chronic stroke patients.
Importantly, ESS is passive in nature, causes patients minimal discomfort, has no
adverse effects, is relatively cheap and can easily be incorporated in regular practice.
Therefore it is valuable to establish the effect of multiple sessions of ESS in the
restoration of upper limb functioning in the acute phase of stroke.
2. Purpose of the project
The overall aim for the present study is to investigate the effect of multiple sessions of
suprasensory ESS in conjunction with occupational therapy (OT)/physiotherapy (PT) training on
recovery of upper limb functioning in acute stroke patients. Suprasensory ESS is defined as
the highest current amplitude that elicits paresthesia in the absence of discomfort, pain and
visible muscle twitches. Specifically, we wish to address the following:
1. Does continuous, suprasensory ESS in conjunction with OT/PT training:
a) reduce impairments, b) improve motor skills required to ADL-performance, and c)
reduce disability,
2. Are changes that can be observed at the end of the intervention still present by 6
months post-stroke? (long-term effect)
3. Hypotheses
We expect that continuous, suprasensory ESS is more effective than intermittent, suprasensory
ESS. The total time of electrical stimulation during a single, intermittent ESS session will
be 1 minute corresponding to 1/60 of the electrical stimulation time during a single,
continuous ESS session. Furthermore, we expect brain reorganisation to proceed and covariate
with recovery.
4. Methods
4.1. Study participants
The trial subjects will be recruited from patients admitted to the stroke unit of Bispebjerg
Hospital, Copenhagen, Denmark. The stroke unit consists of an acute unit and a rehabilitation
unit, and serves a well-defined urban catchment area with a population of approximately
400,000 citizens.
4.2. Procedure, including recruitment of study participants
All patients consecutively admitted to the rehabilitation stroke unit will be screened for
inclusion and exclusion criteria immediately after admission. Emma Ghaziani, daily project
leader, or other health care personnel involved in the study (e.g. the persons delivering
ESS) will take personal contact to each eligible patient as soon as the patient's medical
condition allows it. The patient is first asked if he/she is interested in receiving
information on the study. If so, the written information is handed out, the information
interview is scheduled, and the patient is informed about the possibility of having a
companion (e.g. a relative, a friend) present at the information interview. If necessary, the
patient may get assistance in contacting the companion in this regard. The information
interview will be performed by Emma Ghaziani or other health care personnel involved in the
study and will take place at the patient's bedside. The patient's bed will be screened off
from the rest of the ward and no other visitors will be present. The declaration of consent
will be collected after the patient has been given a reflection time which is determined with
regard to inclusion criteria d) (i.e. ESS can be initiated within 7 days post-stroke).
Baseline assessment will be performed during the first week post-stroke.
Using a stratified random sampling procedure, the study participants will first be divided
into homogenous subgroups with respect to: a) the ability to perform active finger extension
and b) gender. Active finger extension has shown to be a simple and reliable early predictor
of recovery of upper limb functioning in stroke patients. The patients in each subgroup will
then be randomly assigned to either the continuous or the intermittent group. The therapists
providing OT/PT training and the therapists performing assessments will be blinded to group
allocation. The study participants will be blinded to our hypothesis on which type of
suprasensory ESS is most effective.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05378035 -
DOAC in Chinese Patients With Atrial Fibrillation
|
||
Completed |
NCT03574038 -
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
|
N/A | |
Completed |
NCT03679637 -
Tablet-based Aphasia Therapy in the Acute Phase After Stroke
|
N/A | |
Completed |
NCT03633422 -
Evaluation of Stroke Patient Screening
|
||
Completed |
NCT04088578 -
VNS-supplemented Motor Retraining After Stroke
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Not yet recruiting |
NCT05534360 -
Tenecteplase Treatment in Ischemic Stroke Registry
|
||
Withdrawn |
NCT05786170 -
ERILs Und SNILs Unter SOC
|
N/A | |
Not yet recruiting |
NCT04105322 -
Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients
|
N/A | |
Recruiting |
NCT03132558 -
Contrast Induced Acute Kidney in Patients With Acute Stroke
|
N/A | |
Completed |
NCT02893631 -
Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
|
||
Active, not recruiting |
NCT02274727 -
Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
|
||
Completed |
NCT02225730 -
Imaging Collaterals in Acute Stroke (iCAS)
|
||
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Active, not recruiting |
NCT01581502 -
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Terminated |
NCT00132509 -
FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke
|
Phase 2 | |
Recruiting |
NCT05760326 -
Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients
|